TITAN PHARMACEUTICAL (TTP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (256)	10/8/2003 12:06:07 PM
From: Icebrg	Read Replies (1) of 362

>>Erik, do you remain skeptical of TTP's short term prospects?>> Yes, very. I have sold most of what I held. Their time-line is very much defined by the trials they are now running and they all point towards conclusions sometimes towards the end of next year. The only thing I could imagine having a positive impact would be if Novartis managed to find someone to take the development of iloperidone further. That would create some excitement. The share price has been strong yesterday and today, however. But as we know from Oxigene et. al. - anything can happen. Even if there are no objective reasons for it. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next